UNSPSC 51281651: Gentamicin sulfate

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8X7386QRLV. European Medicines Agency schedules Gentamicin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02327MIG. Gentamicin sulfate generally arises in the molecular formula C21H45N5O11S. The term 'gentamicin sulfate' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule gentamicin sulfate under HS 29419000 and SITC 54139.

Gentamicin sulfate bears US NLM identifiers UMLS ID C0546866 and NCI Concept Code C65803. SMILES: As of Q4 2014, GENTAMICIN SULFATE remains US FDA's Preferred Term for this commodity.

UNSPSC 51281651 Gentamicin sulfate is a Commodity code covering individual pharmaceutical products procured through state and local health agencies and county health departments. The recent opportunities block shows little activity directly aligned with gentamicin sulfate itself; instead, the two indexed solicitations involve related pharmaceutical procurement — one for antibiotic tablets (Doxycycline and Ciprofloxacin) and one for Naloxone and drug deactivation systems. State and local buyers use codes in this family to source injectable and oral antibiotics, antihistamines, anticoagulants, and other single-ingredient pharmaceutical products through piggyback contracts, cooperative purchasing vehicles, and direct competitive bids. The issuing bodies are typically state departments of public health and county health or emergency services departments, often procuring for warehouse stock, emergency preparedness, or community health programs.

The two recent opportunities span Florida and Illinois. The Illinois Department of Public Health awarded a piggyback contract to Chartwell Rx LLC through the MMCAP Infuse consortium in August 2026 for antibiotic tablets totaling $2,999,999.11 over 12 months with two renewal options. Seminole County, Florida posted an IFB in June 2026 for Naloxone and drug deactivation systems with quarterly deliveries, a two-year initial term, and one-year renewal option. Both procurements emphasize electronic bidding, vendor compliance with federal requirements (E-Verify, clean-air and water-pollution-control adherence where federally funded), and inclusion of shipping and delivery costs in pricing. Neither opportunity explicitly required set-aside utilization or domestic product preferences. The gentamicin sulfate code itself shows limited recent direct solicitation activity in the indexed block, suggesting either lower-volume or less-frequently-competed demand compared to broader antibiotic or emergency-pharmaceutical categories.